ArkBio concludes dosing for RSV prevention trial in infants

ArkBio concludes dosing for RSV prevention trial in infants

Submitted by admin on November 25, 2024 - 11:07am
Source: 
Clinical Trials Arena
News Tags: 
AK0610
RSV
clinical trials
ArkBio
Headline: 
ArkBio concludes dosing for RSV prevention trial in infants
snippet: 

AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

Do Not Allow Advertisers to Use My Personal information